Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer.
about
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerA phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative AnalysisProstate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma.Improving outcomes in early prostate cancer: Part I--adjuvant treatment.A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].Evaluating possible predictors of prostate cancer to establish a scoring system for repeat biopsies in Chinese men.
P2860
Q28659468-EB1CD903-CC3A-4F23-AC5A-FDFBC0481811Q34073969-6A487424-916E-480C-88FB-C6F038D16E71Q34417941-4F104176-8973-4180-9822-DB0AD4D04D68Q35582358-C04FDD6B-4F87-4709-BE3E-261C0970E6BEQ36149384-470BB286-46D8-4784-BFD1-7E1363CC18E1Q36595214-F9A4C125-D641-486E-BAC1-C2D6C5F3298DQ39508417-8B1AD2B3-6F47-4DB4-9C5B-651CFC690C0BQ39977650-0DCF3432-2A67-4D67-A5D1-C41E8BBE2252
P2860
Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@ast
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@en
type
label
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@ast
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@en
prefLabel
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@ast
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@en
P2093
P1433
P1476
Prostate-specific antigen doub ...... ecurrence for prostate cancer.
@en
P2093
Charles R Pound
Glenn M Cannon
Patrick C Walsh
P356
10.1016/J.UROLOGY.2003.09.009
P407
P478
62 Suppl 1
P577
2003-12-01T00:00:00Z